Chapter 38 The Troubles of Fame
"Chinese scientists have cracked the laws of virus evolution, providing new ideas for the design of broad-spectrum vaccines"
"Chinese scientists propose broad-spectrum vaccine design to combat persistent viral mutations"
"There is a glimmer of hope that the virus will be completely eradicated. The research results of Chinese scientists will help end the global pandemic!"
Starting from a certain year, domestic media completely lost their function of news reporting. For events with news value, they either wait for official notification or reprint foreign news. The depth and breadth of the news are not as good as those of self-media.
Not even as good as, that is, not as good as many down-to-earth self-media.
Chinese media copied reports from overseas media, while Chinese self-media clearly analyzed Chen Yuanguang's glorious past, his scientific research achievements, and the positive significance of his scientific research achievements in ending the virus epidemic.
"The hottest topic in overseas media recently is that a paper published by Chinese scientists in Science is expected to end the global pandemic of the virus in the short term.
To put it simply, the Chinese scientist used simulation methods to calculate the future mutation path of the virus and accurately predicted the mutation points of future virus mutations.
In this way, medical institutions can obtain the mutation points of the virus in advance and design vaccines that cover current and future virus mutation points, so that you don’t have to worry about immune escape when you get the vaccine.
Before, even mRNA viruses were only effective for half a year or even shorter, but with the advent of broad-spectrum vaccines, they can be effective for three years or even longer.
Therefore, the media are saying that the global pandemic is expected to end early with vaccines.
I see that the viewers who sent me private messages in the backstage have a lot of questions, so I picked some typical ones to answer.
Is this a breakthrough? Definitely. His paper has data to verify that his simulation algorithm is correct. In the future, there will be new data to verify his algorithm. This is a major breakthrough in biocomputing in the field of virology.
Considering the context of the times, its significance is even greater.
Can this research result help end the global epidemic of the virus? It has a very positive effect, but I can’t say whether it can completely end it.
Because vaccine research and development costs money, production costs money, and transportation costs money, broad-spectrum vaccines will be more expensive than general mRNA vaccines. Developed countries can afford the injection, but underdeveloped regions such as Africa and the Middle East obviously do not have the money. What if they raise a Gu King there?
I don’t know if it’s completely over, and it’s hard to say.
Who is the author? Why is he so amazing? Oh, I forgot to mention that many viewers must have heard of him. Chen Yuanguang is the author of the original novel of "Kuala Lumpur Past". He graduated from Jiangnan University and went to MIT last year. He published two articles in Nature while in Jiangnan University, and published another article in Nature after going to MIT. This should be his fourth article published in a top journal. He is definitely a genius boy.
All the top journals he had previously published were focused on the field of simulation computing, so there was not much doubt in the academic community about his new achievements this time. His papers were all about the application of simulation computing in chemistry, biology, and virology, which were within his circle of competence.
It's just that his achievements this time have once again made us realize how much impact the combination of deep learning algorithms and biological computing can have. I estimate that the field of biological computing will be very popular in the next few years.
Will he return to China or stay in America? How would I know? I don't know him. I'll ask my friends at Jiangda University if they know him. I'll ask them when the time comes.
He hasn't even graduated yet. With so many top achievements, he can easily get a teaching position at MIT. Why does he need to come back to China to compete? Isn't there a joke that Hawking has to be toasted when he comes to China? But that's not necessarily true. This kind of top talent is in a different track from ours. He doesn't need to compete when he comes back. He can get a teaching position at will. It depends on him.
Can this achievement be awarded the Nobel Prize? I can only say that there is hope, but he is too young. I don’t think it will be awarded to him so soon. The Nobel Prize judges will definitely wait a few years before awarding him.
But he is definitely the most promising winner in the country. Chen Yuanguang's achievements in the fields of biocomputing and computational chemistry are among the best. It is no exaggeration to say that he is a leader in this field. Moreover, he is very young, only in his early twenties, so he has great hope of winning the award in the future.
I can only say that we are both in our early twenties, and I am still worried about graduating with a PhD. I make a living by posting videos on Bilibili and becoming an internet celebrity. Why do I feel more and more sad the more I talk about it? "The video of a certain Bilibili up master is much more detailed than the reports of the Chinese media.
Chen Yuanguang's achievements have sparked heated discussions around the world, and large pharmaceutical groups are rapidly beginning research and development of broad-spectrum vaccines.
Everyone knows that compared with the latest broad-spectrum vaccines, mRNA is no longer popular, and broad-spectrum vaccines are the future.
“Pangalos, how is the communication with Light Chen?
Did he accept our offer?" asked Daubert, executive vice president and president of AstraZeneca's biopharmaceuticals division.
Pangalos shook his head: "Chen firmly rejected our invitation. He probably still wants to stay in the academic world.
I think we need to find a different way to work with Chen. For top scientists like him, they always want to stay in the ivory tower rather than come to the industry in the early stages of their careers.
I thought about it later and decided that we could definitely adopt a cooperative approach. We could hire him as a special consultant, and his subsequent results on the simulated evolution of the COVID virus would only be shared with AstraZeneca, rather than made public.
In this way, our vaccine will have a longer period of effectiveness, which is our exclusive advantage. With the help of AstraZeneca's advantages in Europe, European governments will only consider AstraZeneca, and we will monopolize the entire European market.
Even if Pfizer asks American to coordinate, we can use this advantage to make American have nothing to say. "
Daubert thinks this is a good idea, but he has big doubts about whether the EU can reject America's request.
Even though their vaccine is far ahead of Pfizer's, the EU government has to give Pfizer a certain share.
But this is not important. Even if it is only a majority of the shares, it is enough for AstraZeneca to give the board of directors an extremely good answer this year, and they as executives can also get generous dividends.
AstraZeneca is not the only one who has thought of this. Pfizer and Merck have also thought of this.
Chen Yuanguang was annoyed by the constant interruptions, so he chose to cut the Gordian knot and sent a message to the group on WhatsApp, saying that he would no longer do simulation calculations in this area and would switch to other research directions later, and then turned off his phone.
Why did he make this choice? Because the compensation for being a special consultant to these pharmaceutical companies and keeping the papers confidential is not much, while he, as a best-selling author and IP owner, earns much more than that.
His simulation calculation method has been made public, and these pharmaceutical companies can come up with a rough result by following his method. Therefore, they are unwilling to offer high prices and the price they offer is very limited.
(End of this chapter)